![Eric Carter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Carter
Director/Board Member at
AEON BIOPHARMA, INC.
Net worth: - $ as of 2026-05-30
Profile
Eric G.
Carter currently works at AEON Biopharma Sub, Inc., as Non-Executive Director from 2023, Visgenx, Inc., as Director from 2022, and AEON Biopharma, Inc., as Independent Director from 2023.
Dr. Carter also formerly worked at Bioniz Therapeutics, Inc., as Director from 2016 to 2022, Adverum Biotechnologies, Inc., as Independent Director from 2017 to 2021, Allergan, Inc., as Chief Medical Officer & Senior Vice President from 2011 to 2015, KP Pharmaceuticals LLC, as Chief Scientific & Medical Officer from 2009 to 2011, GSK Plc, as Vice President & Global Head from 1999 to 2009, Lundbeck Seattle BioPharmaceuticals, Inc., as Chief Medical Officer from 2018 to 2019, The University of North Carolina at Charlotte, as Associate Professor, and IACTA Pharmaceuticals, Inc., as Chief Marketing Officer.
Dr. Carter received his doctorate degree from the University of Cambridge, undergraduate degree from the University of London, doctorate degree from the University of Miami, and doctorate degree from The University of Miami Leonard M.
Miller School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-20 | 0 ( -.--% ) | - $ | 2026-05-30 |
Eric Carter active positions
| Companies | Position | Start |
|---|---|---|
| AEON BIOPHARMA, INC. | Director/Board Member | 2023-05-31 |
AEON Biopharma Sub, Inc.
 AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology Manufactures and wholesales pharmaceuticals | Director/Board Member | 2023-07-23 |
Visgenx, Inc.
 Visgenx, Inc. BiotechnologyHealth Technology Develops therapeutics to protect against the loss of sight from retinal disorders | Director/Board Member | 2021-12-31 |
Former positions of Eric Carter
| Companies | Position | End |
|---|---|---|
Bioniz Therapeutics, Inc.
 Bioniz Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage biotechnology company | Director/Board Member | 2022-01-31 |
| ADVERUM BIOTECHNOLOGIES, INC. | Director/Board Member | 2021-05-11 |
| ALDER BIOPHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2019-01-16 |
| ALLERGAN, INC. | Chief Tech/Sci/R&D Officer | 2014-12-31 |
KP Pharmaceuticals LLC
 KP Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets and sells generic pharmaceutical products | Chief Tech/Sci/R&D Officer | 2010-12-31 |
Training of Eric Carter
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
52
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
KP Pharmaceuticals LLC
KP Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets and sells generic pharmaceutical products | Health Technology |
Bioniz Therapeutics, Inc.
Bioniz Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage biotechnology company | Commercial Services |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
The University of Miami Leonard M. Miller School of Medicine
 The University of Miami Leonard M. Miller School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology Manufactures and wholesales pharmaceuticals | Health Technology |
IACTA Pharmaceuticals, Inc.
 IACTA Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and commercializes eyecare products | Health Technology |
Visgenx, Inc.
Visgenx, Inc. BiotechnologyHealth Technology Develops therapeutics to protect against the loss of sight from retinal disorders | Health Technology |
AEON Biopharma, Inc.
 AEON Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company for neurology and gastroenterology markets | Health Technology |
- Stock Market
- Insiders
- Eric Carter
